UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply

The Journal of urology, 2023-12, Vol.210 (6), p.839-839

2023

Link zum Volltext

Verfügbarkeit prüfen

Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study

Cancers, 2023-06, Vol.15 (11), p.3051

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting

Cancers, 2022-08, Vol.14 (16), p.3896

2022

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply

The Journal of urology, 2022-02, Vol.207 (2), p.476-477

2022

Link zum Volltext

Verfügbarkeit prüfen

Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities

Urology (Ridgewood, N.J.), 2022-05, Vol.163, p.148-155

2022

Link zum Volltext

Verfügbarkeit prüfen

Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer

Hematology/oncology clinics of North America, 2021-06, Vol.35 (3), p.513-529

2021

Link zum Volltext

Verfügbarkeit prüfen

Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?

European urology, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs

Urology (Ridgewood, N.J.), 2021-11, Vol.157, p.181-187

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder

BJU international, 2022-11, Vol.130 (5), p.604-610

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience

The Journal of urology, 2024-02, Vol.211 (2), p.241-255

2024

Link zum Volltext

Verfügbarkeit prüfen

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic

The Journal of urology, 2023-01, Vol.209 (1), p.140-149

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre

BJU international, 2022-09, Vol.130 (3), p.323-330

2022

Link zum Volltext

Verfügbarkeit prüfen

All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors

The Journal of urology, 2022-08, Vol.208 (2), p.284-291

2022

Link zum Volltext

Verfügbarkeit prüfen

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply

The Journal of urology, 2023-08, Vol.210 (2), p.254-255

2023

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system

BJU international, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy

The Journal of urology, 2021-09, Vol.206 (3), p.577-585

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline Predisposition to Prostate Cancer in Diverse Populations

Urologic clinics of North America, 2021-08, Vol.48 (3), p.411-423

2021

Link zum Volltext

Verfügbarkeit prüfen

Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study

The Journal of urology, 2022-10, Vol.208 (4), p.886-895

2022

Link zum Volltext

Verfügbarkeit prüfen

Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

The Journal of urology, 2021-11, Vol.206 (5), p.1258-1267

2021

Link zum Volltext

Verfügbarkeit prüfen

Pelvic Organ Preservation in Non–muscle-invasive Bladder Cancer: Less Is More

European urology focus, 2023-07, Vol.9 (4), p.571-574

2023

Link zum Volltext

Verfügbarkeit prüfen

Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response

BJU international, 2021-11, Vol.128 (5), p.634-641

2021

Link zum Volltext

Verfügbarkeit prüfen

Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?

BJU international, 2022-10, Vol.130 (4), p.463-469

2022

Link zum Volltext

Verfügbarkeit prüfen

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

JAMA network open, 2022-03, Vol.5 (3), p.e223050-e223050

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of upper tract urothelial carcinoma on response to BCG in patients with non‐muscle‐invasive bladder cancer

BJU international, 2021-11, Vol.128 (5), p.568-574

2021

Link zum Volltext

Verfügbarkeit prüfen

Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response

BJU international, 2021-11, Vol.128 (5), p.634-641

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(51)
Bücher
(1)

Sprache

Englisch
(52)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Urology & Nephrology
(23)
Humans
(21)
Female
(13)
Bladder Cancer
(12)
Male
(12)
Aged
(8)
Cystectomy
(8)
Middle Aged
(8)
Oncology
(7)
Urinary Bladder Neoplasms - Drug Therapy
(7)
Neoplasm Invasiveness
(6)
Retrospective Studies
(6)
Urinary Bladder Neoplasms - Pathology
(6)
Urinary Bladder Neoplasms - Surgery
(6)
Bcg Vaccine - Therapeutic Use
(5)
Invasiveness
(5)
Tumors
(5)
Adolescent
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Repeat Transurethral Resection of Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply

Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting

Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy. Reply

Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities

Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer

Challenging the Paradigm of “BCG-unresponsive” Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?

What Women Want: Radical Cystectomy and Perioperative Sexual Function Educational Needs

Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder

Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not Therapeutic

Reduced‐dose bacillus Calmette‐Guérin (BCG) in an era of BCG shortage: real‐world experience from a tertiary cancer centre

All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors

Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. Reply

Racial disparities in stage at bladder cancer diagnosis in the US Veterans Affairs healthcare system

Contemporary Rates of Gynecologic Organ Involvement in Females with Muscle Invasive Bladder Cancer: A Retrospective Review of Women Undergoing Radical Cystectomy following Neoadjuvant Chemotherapy

Germline Predisposition to Prostate Cancer in Diverse Populations

Apixaban vs Enoxaparin for Post-Surgical Extended-Duration Venous Thromboembolic Event Prophylaxis: A Prospective Quality Improvement Study

Progression of Disease after Bacillus Calmette-Guérin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy

Pelvic Organ Preservation in Non–muscle-invasive Bladder Cancer: Less Is More

Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response

Should patients with non‐muscle‐invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette–Guérin?

Management, Surveillance Patterns, and Costs Associated With Low-Grade Papillary Stage Ta Non-Muscle-Invasive Bladder Cancer Among Older Adults, 2004-2013

Impact of upper tract urothelial carcinoma on response to BCG in patients with non‐muscle‐invasive bladder cancer

Time interval from transurethral resection of bladder tumour to bacille Calmette–Guérin induction does not impact therapeutic response

Suchergebnisse filtern